Eaton Vance Worldwide Health Sciences Fund
Registrant
Eaton Vance Growth Trust
Class tickers
ECHSX
EIHSX
ERHSX
ETHSX
Net Assets
$806,188,451
Holdings
26
Latest Report
Aug 31, 2026
Net Assets Over Time
Holdings · 26
Export CSV
Portfolio coverage: 26 of
41 reported positions.
| Holding | Symbol | Balance | Value | % of Fund | Side | Category | Open |
|---|---|---|---|---|---|---|---|
| Eli Lilly & Co | LLY | 83,346 | $96,408,819 | 11.96% | Long | EC | |
| Johnson & Johnson | JNJ | 216,808 | $57,638,407 | 7.15% | Long | EC | |
| AbbVie Inc | ABBV | 224,713 | $57,620,907 | 7.15% | Long | EC | |
| Merck & Co Inc | MRK | 324,173 | $47,899,802 | 5.94% | Long | EC | |
| UnitedHealth Group Inc | UNH | 109,349 | $42,581,594 | 5.28% | Long | EC | |
| Bristol-Myers Squibb Co | BMY | 513,118 | $34,281,414 | 4.25% | Long | EC | |
| Vertex Pharmaceuticals Inc | VRTX | 56,632 | $30,837,257 | 3.83% | Long | EC | |
| Abbott Laboratories | ABT | 240,391 | $26,529,551 | 3.29% | Long | EC | |
| Gilead Sciences Inc | GILD | 180,882 | $26,470,272 | 3.28% | Long | EC | |
| Thermo Fisher Scientific Inc | TMO | 41,239 | $25,448,587 | 3.16% | Long | EC | |
| Intuitive Surgical Inc | ISRG | 56,833 | $21,418,084 | 2.66% | Long | EC | |
| Danaher Corp | DHR | 79,206 | $16,915,233 | 2.10% | Long | EC | |
| Stryker Corp | SYK | 51,623 | $16,715,527 | 2.07% | Long | EC | |
| Argenx SE | ARGX | 14,849 | $15,319,119 | 1.90% | Long | EC | |
| CVS Health Corp | CVS | 159,207 | $14,951,129 | 1.85% | Long | EC | |
| Quest Diagnostics Inc | DGX | 57,117 | $13,725,215 | 1.70% | Long | EC | |
| Mettler-Toledo International Inc | MTD | 8,632 | $12,129,168 | 1.50% | Long | EC | |
| Neurocrine Biosciences Inc | NBIX | 78,152 | $12,037,753 | 1.49% | Long | EC | |
| HeartFlow Inc | HTFL | 216,487 | $10,908,780 | 1.35% | Long | EC | |
| Cooper Cos Inc/The | COO | 126,763 | $8,884,819 | 1.10% | Long | EC | |
| Caris Life Sciences Inc | CAI | 275,438 | $7,020,915 | 0.87% | Long | EC | |
| Xenon Pharmaceuticals Inc | XENE | 99,010 | $5,962,382 | 0.74% | Long | EC | |
| Medline Inc | MDLN | 145,899 | $5,110,842 | 0.63% | Long | EC | |
| Generate Biomedicines Inc | GENB | 308,946 | $4,717,605 | 0.59% | Long | EC | |
| Enliven Therapeutics Inc | ELVN | 37,350 | $2,162,192 | 0.27% | Long | EC | |
| MBX Biosciences Inc | MBX | 31,519 | $1,941,570 | 0.24% | Long | EC |